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INTRODUCTION
Extranodular lymphoma can be found in almost all
organ. Gastrointestinal (GI) tract involvement
comprises one third of all lymphoma cases, which is
the commonest form of extranodular lymphoma.
If tonsillar and Waldeyer ring are included, then
the head and neck are the second most common sites,
which comprise one fifth of all the cases.1 Etiologies
of extranodular lymphoma seem to be multifactorial
which includes immune system suppression, viral and
bacterial infection, pesticide exposure and other
environmental factors.2 Geographic differences
indicate that the incidence of Epstein-Barr virus
infection and human T-cell lymphotropic virus1-
associated T-cell lymphomas is higher in Asia than in
Europe and North America.2
All subtypes of lymphoma can occur as primary
lesion of GI tract, but the most common type is B-cell
diffuse large cell lymphoma subtype.3 Histological
subtype is the main predictors for prognosis in nodal
and extranodal lymphoma, but the location of primary
lesion is the most determining factors for aggressive
extranodal lymphoma.2 Despite for its rare occurrence,
this tumor poses a threat for surgeons, oncologist, and
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ABSTRACT
Extranodular lymphoma can be found in almost all organ. One third of the cases found in
gastrointestinal (GI) tract, which is the most common form of extranodular lymphoma. All the subtypes of
lymphoma may occur as primary lesion along in gastrointestinal tract, but the most common form is
B-cell diffuse large cell lymphoma. Diseases that linked with GI tract lymphoma are inflammatory bowel
disease, celiac disease, Helicobacter pylori, virus infection, collagen disease and ionic radiation.
This report described a 40 years old man with recurrent bloody stool and colon lymphoma was blamed as
the source of bleeding with its management of lymphoma.
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interventional radiologist in determining optimal
therapy. This report describes a 40 years old man with
recurrent bloody stool, with its management
CASE ILLUSTRATION
A male 44 years old, came with complaints of bloody
stools since six months before hospital admission. Two
months ago the patient often feels weak, loss of
appetite, and looked pale. The patient weight loss of
9 kg in three months. The patient to a local hospital in
Padang and underwent colonoscopy examination.
Hyperemic sigmoid mucosa and descending colon were
found, slight bleeding were also seen in this area.
Biopsy results were diagnosed as atypical chronic
colitis and not visible signs of malignant. Mesalazine
500 mg three times daily, budesonide three times daily,
mebeverin HCl twice daily were prescribed for the
treatment. The stools remained bloody and several
transfusions have been made for the patient.
Abdominal pain in right lower quadrant was also
complained. There is no evident of malignancy in
patient’s family history. Patient sought medical
attention in Cipto Mangunkusumo hospital.
Physical examination found moderate illness,
conscious, blood pressure was 120/80 mmHg, heart
rate was 80 times/minute, respiration rate was 18 times/
minute, body temperature was 36.50C, conjunctiva
was pale, while no jaundice found in sclera. No
abnormality of heart and lungs in the examination, pain
on palpation was found in right lower quadrant.
Volume 11, Number 1,  April  2010 41
Primary Gastrointestinal Tract Lymphoma
Laboratory result showed hemoglobin 10.9 g/dL,
leukocyte 8,440/uL, platelet 336,000/uL, mean
corpuscular volume 74.6 fl, mean corpuscular
hemoglobin 23.1 pg, mean corpuscular hemoglobin
concentration 31 g/dL, AST 21 U/L, ALT 35 u/L,
random blood glucose 160 mg/dL, alkali phosphatase
133 u/L, uric acid 6.4 mg/dL, lactate dehydrogenase
244 u/L, iron serum 25 ug/dL, total iron binding
capacity 195 ug/dL, ferritine 76.96 ng/mL, albumin
3 g/dL, prothrombin time (PT) 12.3 seconds (control
PT: 12.6 second), activated partial thromboplastin time
(APTT) 38.1 second (control APTT 36.8 second), anti
tuberculosis negative, CEA 1.4 ng/mL, CA 19-9 7.8
U/mL. 3 times fecal BTA negative, anti Helicobacter
pylori Ig G negative.
Electrocardiography (ECG) reading was within
normal limit, thoracal radiology was suspected
lymph nodes enlargement in left thoracal plexus,
abdominal CT-scan found caecal tumor, with
ulcerative colitis as the differential diagnosis.
Follow through examination profound colon
carcinoma at ascendence colon-caecum which
was also infiltrate terminal ileum. Conclusion from
colonoscopy was caecal colon cancer and grade II
internal hemorrhoid. Biopsy identified suspect of
malignant non-Hodgkin lymphoma, classified
as monocytoid/marginal zone B cell lymphoma
subtype. Esophagogastroduodenoscopy was normal.
The patient was planned to have right hemi-
colectomy for tumor resection and ileo anastomoses
transversustomy. Microscopic pathology showed
malignant lymphoma, perhaps subtype of anaplastic
large cell lymphoma (ALCL). Immuno-histochemical
test result found positive reaction of CD 20 and
negative reaction of CD 3, CD 10, and CD 38, these
findings was concluded to be associated with
malignant large B cell lymphoma. No abnormality was
found in bone marrow preparation. From bone
marrow aspiration, histological associated with
hypocellularity but no malignancy was observed. Post-
surgery abdominal CT-scan did not find lymph nodes
enlargement and no intraabdominal mass was found.
Thoracal CT-scan exhibits segmental pneumonia in
inferior lobe of both lungs with fibrotic component
and minimal parapneumonic effusion (tuberculosis
suspect) and there was neither metastatic sign nor
lymph nodes enlargement. CHOP chemotherapy was
planned for the patient for 6-8 cycles.
Figure 1. Based on microscopic examination of the biopsy,
suspected of malignant non-Hodgkin lymphoma, subtype
monocytoid/marginal zone B cell lymphoma
Figure 2. Malignant lymphoma was observed of post operative
histopathology results
Figure 3. Result of bone marrow biopsy showed hypocellularity of
the bone marrow was apparent. There was not appear of
malignant tumor cell
 
Figure 4. Immunohistochemical showed CD 20 positive, malignancy
in diffuse large B-cell cell lymphoma
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DISCUSSION
GI tract is the most common extranodal site from
non-Hodgkin lymphoma. Hospital based and
population based publication suggested that non-
Hodgkin lymphoma approximately occur in 4-20%
(with average of 12-13%) of all non-Hodgkin lymphoma
cases and comprised 30-40% of all extranodal cases.1
In Europe, the most common location is gaster
(approximately 50-60%), small bowel (+ 30%), and
large bowel (+ 10%).1,4 In Middle Asia most of
primary GI tract lymphoma occurs in small bowel and
gaster.4 In Indonesia the prevalence of GI tract
lymphoma is still unknown. In this case, there was
only one extranodal location have been found and
was not found in other location. The diagnosis of
primary GI tract lymphoma was established by the
presence of lymphoproliferative neoplasm from
histological examination without any palpable
adenopathy and hepatosplenomegaly and no prove of
lymphoma in thoracal X-ray nor in CT-scan,
peripheral blood smear, or bone marrow aspiration and
biopsy.5
In this case, it was not clear whether this lymphoma
was the progression of colitis or not. Cohort study based
on population and patient suggested that the risk of
lymphoma in inflammatory bowel disease is low with
absolute risk as low as 0.03% per person-year. Data
taken from the hospital has suggested that severe
inflammatory bowel disease (IBD) patients have higher
possibility to suffer lymphoma, although population
based study did not find any increase of risk of
lymphoma in IBD patients.6 Patients with celiac
disease increase the risk of intestinal lymphoma up to
200 fold, this condition described as enteropathy-
associated T-cell lymphoma.1,7 Other causes that has
been linked with GI tract lymphoma are virus, collagen
disease, and ionic radiation.3 Just like stomach
mucosa-associated lympholid tissue (MALT) disease,
there is obvious relation between bowel MALT and
Helicobacter pylori infection.7 MALT can occur in
almost every organ as response of persistent
stimulation like chronic infections or autoimmune
process. In uncontrolled proliferation of lymphoid,
malignant clones could be generated and continue
to progress to form MALT lymphoma.8 Other
diseases that associated with non-Hodgkin
lymphoma are Sjogren syndrome, rheumatoid
arthritis; Epstein-Barr virus infection is linked with
Burkitt lymphoma; primary effusion lymphoma
is related with a human herpes virus  infection,8
and Chlamydia psittaci infection is linked with
ocular adnexal lymphomas.9 Prevalence of non-
Hodgkin lymphoma increased in immunocompromised
patient. Non-Hodgkin lymphoma which related with
AIDS have specific characteristic: usually spread to
other location, commonly extranodal, and all extranodal
location could be involved (central nervous system,
bone marrow, gastrointestinal, and atypical location like
anus and rectum, oral cavity, and heart) and
the prognosis is very poor.10
Primary lymphoma in this case was occured in
caecum area. It was already mentioned that common
sites of large bowel lymphoma are caecum and
rectum.1,5,11 CT-scan could not distinguished between
lymphoma and adenocarcinoma of colon.11
The type of lymphoma in this patient was
malignant B cell diffuse large cell lymphoma, it was
proven by histology and immunohistochemical
examination. Almost primary intestinal lymphoma was
B cell origin and most of B cells are high degree
tumors.7 Fifty until seventy percents of GI tract
lymphomas are aggressive types and prognostically not
preferable, which are diffuse large cell and
immunoblastic lymphoma.5
Based on tumor node metastasis (TNM) classifi-
cation, this patient was on stage IE-B, in which there
was only local involvement in one extralymphatic
organ and there was prodromal symptoms like weight
loss. It is important to seek the spread of all primary
GI tract non-Hodgkin lymphoma in purpose of
choosing the therapy, whether it would be surgery or
chemotherapy.5
After tumor resection, this patient was given CHOP
regimens, which consist of cyclophosphamid
750 mg/m2, doxorubicin 50 mg/m2, vincristine
1.4 mg/m2 and prednison 100 mg/m2, this regimen was
planned for 6-8 cycles with 3 weeks interval. Curative
tumor resection increase the 5-years survival rate up
to more than 75%.12 Gastrointestinal lymphoma is
more radiosensitive and more responsive to chemo-
therapy compared with adenocarcinoma.12 The risk
of radiation complication like perforation and bleeding
and also chemotherapy adverse reaction like bone
marrow suppression would be decreased if they were
done after surgical resection.12 In GI  tract lymphoma,
adjuvant chemotherapy after surgical resection would
also reduce the recurrency and increase survival
rate.12,13,14 Although few randomized study that
compares surgical resection as single therapy and
adjuvant chemotherapy, recently the combination of
modalities are the choice of therapy for primary
intestinal lymphoma.1
The prognosis of this patient was good since
patient classified as grade IE, which has long term
survival rate of approximate 60-80%.5 The only
important prognostic factor of intestinal lymphoma in
western countries are clinical grading, in which 5-years
survival rate is around 40-50 % for grade I-II and less
than 10% in more severe grade.4
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